This image provided by Lucy O’Donoghue shows a children playing by a lake. Although this year’s quarantine limited Lucy O’Donoghue’s opportunities for travel, she found ways to focus on her two sons by taking them for ‘micro-holidays’ at a beach near their
Maliheh Rahimi crochets at a workshop of Bavar charity in Tehran, Iran, Monday, Nov. 23, 2020. As the coronavirus pandemic ravages Iran, a women’s group hopes to empower its members by helping them make and sell face masks. (AP Photo/Vahid Salemi)
FILE – In this Nov. 30, 2016, file photo, French fashion designer Pierre Cardin acknowledges applause after a show to mark 70 years of his creations, in Paris. France’s Academy of Fine Arts says famed fashion designer Pierre Cardin has died at
In a career spanning more than three-quarters of a century, he remained a futurist, reproducing fashions for ready-to-wear consumption and affixing his brand to an outpouring of products. — NYT: Top Stories
JERSEY CITY, N.J.–(BUSINESS WIRE)–DLCC, an institutional grade crypto Prime Brokerage software and service solution, today appointed blockchain and capital markets expert Jeanine Hightower-Sellitto to its Board of Directors, effective immediately. DLCC’s mission is to bridge the gap between legacy finance and alternative
The vote tonight could set up the first veto override of his presidency. The bill passed by overwhelming margins, though some Republicans who voted for it have indicated they will sustain his veto. — NYT: Top Stories
The measure will bring $600 checks for most Americans, and restore lapsed jobless benefits, in the face of what Dr. Anthony Fauci warns may be a further post-holiday surge in cases. — NYT: Top Stories
Nick McGlashan, known as a deck boss on Discovery’s “Deadliest Catch,” has died. He was 33 years old. — FOX News
Marketing Authorization Application is supported by positive results from the pivotal Phase 3 True North study evaluating oral Zeposia (ozanimod) in adults with moderately to severely active ulcerative colitis If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for